不能攝取適當食物之患者之補助治療劑，蛋白質之消化吸收機能及合成利用障礙，嚴重創傷、火傷、骨折時蛋白質之補給，蛋白質攝取減少營養失調症。

胺基酸溶液，主要為提供氮來源以合成蛋白質。

Onset of action: 1 to 2 weeks Duration of action: 1 to 2 days Absorption: Rapid Distribution: Vd: ~20 to 47 L/kg (Laizure 1985) Protein binding: 84% Metabolism: Extensively hepatic via CYP2B6 to hydroxybupropion; non-CYP-mediated metabolism to erythrohydrobupropion and threohydrobupropion. Metabolite activity ranges from 20% to 50% potency of bupropion. Bupropion also undergoes oxidation to form the glycine conjugate of meta-chlorobenzoic acid, the major urinary metabolite. Half-life: Distribution: 3 to 4 hours Elimination: Hydrochloride salt: ~21 hours after chronic dosing (± 9 hours); Metabolites (after a single dose): Hydroxybupropion: 20 ± 5 hours; Erythrohydrobupropion: 33 ± 10 hours; Threohydrobupropion: 37 ± 13 hours Hydrobromide salt: 21 ± 7 hours; Metabolites: Hydroxybupropion: 24 ± 5 hours; Erythrohydrobupropion: 31 ± 8 hours; Threohydrobupropion: 51 ± 9 hours Time to peak, serum: Bupropion: Immediate release: Within 2 hours; 12-hour extended release (sustained release): Within 3 hours; 24-hour extended release: ~5 hours; 12 hours (fed) Metabolite: Hydroxybupropion: Immediate release: ~3 hours; Extended release: ~6 to 7 hours Excretion: Urine (87%, primarily as metabolites); feces (10%, primarily as metabolites)

嚴重腎功能不全者。

注射速度太快時，會有輕微灼熱感，極少有惡寒或體溫上升之過敏反應。 (建議以超過2hrs慢速點滴輸注,可有效避免產生此副作用)

治療初期每天2公撮的速利清做肌肉或靜脈的注射，然後治療間隔加長至兩或三天。較輕的症狀每一治療過程需10~15針，較重的症狀則視需要可加長至數個治療過程。高劑量使用5公撮或10公撮安瓿裝：每天5-40公撮緩慢的靜脈注射或點滴注射。根據病況每一治療過程 10至15針，如需要可連續數個治療過程。

嚴重腎功能不全不建議使用

室溫(25℃以下)儲存。藥品稀釋後室溫可保存 24 小時。